Se-cure Pharmaceuticals Inc. is a subsidiary company of Se-cure Pharmaceuticals Ltd. Pharmaceuticals Ltd. is a research-driven biotech company focused on the discovery and development of therapeutic solutions originating from botanical sources with an emphasis on safety of use. The proprietary solutions developed combine the best of the pharmaceutical and nutraceutical world, balancing Science and Nature.
Se-cure manufactures the products developed in-house in a state of the art pharmaceutical grade manufacturing facility operating under rigorous quality control standards of cGMPs, ISO 9001:2008, HACCP, and the environmental quality control- ISO 14001:2004.
The manufacturing procedure of Brizo® follows the highest industry standards. Comprehensive microbiological and biochemical testing are rigorously performed throughout the process. We are committed to making each and every capsule identical in its therapeutic characteristics within the accepted standards.
The Femarelle® Line supports women in the different stages of estrogen decline*. The Femarelle® line launched in 2000 and is quickly positioned as the best therapy for the management of menopause, in all the markets it enters.
Brizo® was launched in 2011 and provides optimal prostate health in men*. Brizo® offers a completely fresh approach for the management of urinary frequency and urgency, providing swift relief, without exposure to unnecessary risks*. With Brizo® the quality of life is regained without any undesirable side effects*.
Our team is dedicated to creating supplements that provide proven relief of symptoms while avoiding the risks of the conventional options.
We are dedicated to the highest levels of scientific excellence and commit our research to providing safe and effective options for consumers and healthcare professionals.
For more information www.femarelle.us